The medication must navigate stomach acid and intestinal barriers, then cross into systemic circulationa process requiring careful pharmaceutical engineering through specialized formulations
Protocols should be individualized and supervised by a qualified provider
This might reveal that the go low, go slow approach that compounding allows reduces side effects, improves sustainment and achieves better results
Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, Beal MF, Bergersen LH, Brinton RD, de la Monte S, Eckert A, Harvey J, Jeggo R, Jhamandas JH, Kann O, la Cour CM, Martin WF, Mithieux G, Moreira PI, Murphy MP, Nave KA, Nuriel T, Oliet SHR, Saudou F, Mattson MP, Swerdlow RH, Millan MJ
Differential roles of the mtor-Stat3 signaling in dermal T cell effector function in skin inflammation